… treatment recommendations, 10 the aim of this meta-analysis was to compare the pooled
efficacy and cardiovascular safety data from trials of ICS/LABA/LAMA with ICS/LABA … therapy in …

… The aim of this study was a quantitative synthesis by considering the studies that directly
compared triple ICS/LABA/LAMA vs. either dual LABA/LAMA or ICS/LABA therapies …

… , LAMA/LABAs and ICS/LABAs using published … /LABAs and ICS/LABAs led to a greater
improvement in trough FEV 1 compared with placebo and SAMA monotherapy. All LAMA/LABAs …

… the currently available dual therapies in patients with moderate-to-severe COPD. In particular,
this study aimed to compare and rank LABA/LAMA FDCs and ICS/LABA FDCs on trough …

… with commonly used COPD treatments. The objective of this analysis was to compare the
efficacy and safety of LABA/LAMA with LAMA or LABA/inhaled corticosteroid (ICS) in adults …

… The results of our meta-analysis showed a significant benefit of ICS/LABA … Based on the
results of this meta-analysis, ICS therapy is an important part of the therapeutic armamentarium …

… (ICS). When two classes of medications are required, LAMA plus LABA (LAMA+LABA) and
LABA plus ICS (LABA+ICS) … LABA+ICS, which is compatible with our analysis (Nannini 2012). …

… of these triple therapies, discusses the role of ICS in patients with … ” (ICS/LAMA/LABA) therapy
vs LAMA, ICS/LABA, and LAMA/LABA combinations, and summarizes studies in which ICS/…

… meta-analysis were original trials written in English comparing the impact of LAMA + LABA
and LABA + ICS for … Compared with LABA + ICS, LAMA + LABA led to significantly greater …

… options (particularly in patients at low risk of exacerbations), we performed a systematic
review and a meta-analysis to determine the effect of ICS/LABA/LAMA combination …